NASDAQ

BridgeBio Pharma, Inc. (BBIO)

♥ 608 Thanks from members

Live price chart, market sentiment, and community perspectives for BridgeBio Pharma, Inc. (NASDAQ: BBIO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Neil KumarFounder: Bain Capital Life SciencesLeadership: Neil Kumar (CEO)Leadership: Charles Craig (CFO)Holder: Bain Capital Life SciencesHolder: Fidelity Management and ResearchHolder: The Vanguard GroupHolder: BlackRock, Inc.ATTR-ACT / AttrubyInfigratinibDofedamenib#BBIO#BridgeBio Pharma#Biotech#Genetic Diseases#Rare Disease Therapeutics